BCL2L10 and hepatocellular carcinoma: We performed bioinformatics analyses of pre-existing global gene expression data from PBMCs of healthy patients, eventually identifying differential expression of BCL2L10. Liu et al. used a more direct approach with their own primary data from various HCC lines before and after treatment with chemotherapeutic agents, also leading to the identification of BCL2L10. However, it's important to note that our studies are certainly more different than theirs.